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Introduction: Emergency department (ED)-initiated palliative care has been shown to improve 
patient-centered outcomes in older adults with serious illnesses, but the optimal modality for 
providing such interventions is unknown. The EMPallA trial compares nurse-led, telephonic case 
management with specialty, outpatient palliative care on: 1) patient quality of life (QOL); 2) 
healthcare utilization; 3) loneliness and symptom burden; and 4) caregiver strain, QOL, and 
bereavement. 
Objective: Summarize preliminary demographic and QOL data for the EMPallA cohort. 
Methods: A pragmatic, parallel, two-arm randomized controlled trial is enrolling 1350 ED 
patients across 9 EDs over 3 years to compare the effectiveness of palliative care models. 
Eligible patients have end-stage heart failure, renal disease, chronic obstructive pulmonary 
disease (COPD), or cancer. Baseline data is collected at bedside using surveys. Functional 
Assessment of Cancer Therapy - General (FACT-G) QOL scores are rescaled into T-scores 
based on general US and cancer patient samples, standardized with mean 50 and standard 
deviation 10. 
Results: 138 patients enrolled from April 16 to October 16, 2018. Average age was 69 years; 
55% were female, and 55% were white. Advanced cancer was most prevalent (48%), followed 
by heart failure (24%), COPD (23%), and end-stage renal disease (15%). Average FACT-G T-
scores were 41 (general population) and 40 (cancer patients), which are below population means 
of 50 by more than 5, a clinically-meaningful difference. 
Discussion: This gender-balanced, racially-diverse cohort stands to benefit in QOL from 
palliative care. When trial enrollment and follow-up are complete, the impact of interventions 
can be assessed. 
